NOVEL, FIRST-IN-CLASS, FATTY ACID SYNTHASE (FASN) INHIBITOR TVB-2640: EFFICACY, SAFETY AND BIOMARKER RESULTS FROM A GLOBAL PHASE 2 RANDOMIZED PBO-CONTROLLED NASH TRIAL, FASCINATE-1
GASTROENTEROLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要